<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>11(1)</volume><submitter>Rey E</submitter><journal>Clinical and translational medicine</journal><pagination>e275</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7810262</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Sofosbuvir improves HCV-induced insulin resistance by blocking IRS1 degradation.</pubmed_title><pmcid>PMC7810262</pmcid><pubmed_authors>Munoz-Hernandez R</pubmed_authors><pubmed_authors>Garcia-Garcia Y</pubmed_authors><pubmed_authors>Rey E</pubmed_authors><pubmed_authors>Gonzalez-Rodriguez A</pubmed_authors><pubmed_authors>Maranon P</pubmed_authors><pubmed_authors>Garcia-Monzon C</pubmed_authors><pubmed_authors>Romero-Gomez M</pubmed_authors><pubmed_authors>Ampuero J</pubmed_authors><pubmed_authors>Molina-Jimenez F</pubmed_authors><pubmed_authors>Majano P</pubmed_authors></additional><is_claimable>false</is_claimable><name>Sofosbuvir improves HCV-induced insulin resistance by blocking IRS1 degradation.</name><description/><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Jan</publication><modification>2025-04-25T17:43:58.964Z</modification><creation>2025-04-25T17:43:58.964Z</creation></dates><accession>S-EPMC7810262</accession><cross_references><pubmed>33463051</pubmed><doi>10.1002/ctm2.275</doi></cross_references></HashMap>